Endoscopic Ultrasound-Guided Fine Needle Aspirate Microsatellite Loss Analysis and Pancreatic Endocrine Tumor Outcome

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 12, 2006, Pages 1474-1478

  Nodit, Laurentia ^a   McGrath, Kevin M ^a   Zahid, Maliha ^b   Jani, Niraj ^a   Schoedel, Karen E ^a   Ohori, N Paul ^a   Carty, Sally ^c   Finkelstein, Sydney ^d   Khalid, Asif ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d RedPath Integrated Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; CANCER GENETICS; CANCER INVASION; CHROMOSOMAL LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOSCOPIC ULTRASOUND GUIDED FINE NEEDLE ASPIRATION; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MICROSATELLITE MARKER; PANCREAS TUMOR; TUMOR CLASSIFICATION; TUMOR GROWTH;

ADULT; AGED; BIOPSY, FINE-NEEDLE; DNA, NEOPLASM; ELECTROPHORESIS, CAPILLARY; ENDOSCOPY, DIGESTIVE SYSTEM; ENDOSONOGRAPHY; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33845462137     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.07.017     Document Type: Article

References (24)

1. Barakat M.T., Meeran K., and Bloom S.R. Neuroendocrine tumors. Endocr Relat Cancer 11 (2004) 1-18
2. Kimura W., Kuroda A., and Morioka Y. Clinical pathology of endocrine tumors of the pancreas. Analysis of autopsy cases. Dig Dis Sci 36 (1991) 933-942
3. Warner R.R. Enteroendocrine tumors other than carcinoid: a review of clinically significant advances. Gastroenterology 128 (2005) 1668-1684
4. Speel E.J., Richter J., Moch H., et al. Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization. Am J Pathol 155 (1999) 1787-1794
5. Speel E.J., Scheidweiler A.F., Zhao J., et al. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas. Cancer Res 61 (2001) 5186-5192
6. Zhao J., Moch H., Scheidweiler A.F., et al. Genomic imbalances in the progression of endocrine pancreatic tumors. Genes Chromosomes Cancer 32 (2001) 364-372
7. Stumpf E., Aalto Y., Hoog A., et al. Chromosomal alterations in human pancreatic endocrine tumors. Genes Chromosomes Cancer 29 (2000) 83-87
8. Barghorn A., Komminoth P., Bachmann D., et al. Deletion at 3p25. J Pathol 194 (2001) 451-458
9. Barghorn A., Speel E.J., Farspour B., et al. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors. Am J Pathol 158 (2001) 1903-1911
10. Jimenez-Heffernan J.A., Vicandi B., Lopez-Ferrer P., et al. Fine needle aspiration cytology of endocrine neoplasms of the pancreas. Acta Cytol 48 (2004) 295-301
11. Kloppel G., Perren A., and Heitz P.U. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 1014 (2004) 13-27
12. Khalid A., Pal R., Sasatomi E., et al. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 53 (2004) 1860-1865
13. Khalid A., McGrath K.M., Zahid M., et al. Pancreatic cyst DNA analysis predicts cyst pathology. Clin Gastroenterol Hepatol 3 (2005) 967-973
14. Furlan D., Cerutti R., Uccella S., et al. Different molecular profiles characterize well-differentiated endocrine tumors and poorly differentiated endocrine carcinomas of the gastroenteropancreatic tract. Clin Cancer Res 10 (2004) 947-957
15. House M.G., Herman J.G., Guo M.Z., et al. Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery 134 (2003) 902-908
16. Goebel S.U., Iwamoto M., Raffeld M., et al. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness. Cancer Res 62 (2002) 3702-3710
17. Lam K.Y., Lo C.Y., Fan S.T., et al. Telomerase activity in pancreatic endocrine tumors: a potential marker for malignancy. Mol Pathol 53 (2000) 133-136
18. Hessman O., Lindberg D., Einarsson A., et al. Genetic alterations on 3p, 11q13, and 18q in nonfamilial and MEN 1-associated pancreatic endocrine tumors. Genes Chromosomes Cancer 26 (1999) 258-264
19. Hessman O., Skogseid B., Westin G., et al. Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. J Clin Endocrinol Metab 86 (2001) 1355-1361
20. Guo S.S., Wu A.Y., and Sawicki M.P. Deletion of chromosome 1, but not mutation of MEN-1, predicts prognosis in sporadic pancreatic endocrine tumors. World J Surg 26 (2002) 843-847
21. Guo S.S., Arora C., Shimoide A.T., et al. Frequent deletion of chromosome 3 in malignant sporadic pancreatic endocrine tumors. Mol Cell Endocrinol 190 (2002) 109-114
22. La Rosa S., Sessa F., Capella C., et al. Prognostic criteria in nonfunctioning pancreatic endocrine tumors. Virchows Arch 429 (1996) 323-333
23. Panzuto F., Nasoni S., Falconi M., et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 12 (2005) 1083-1092
24. Zikusoka M.N., Kidd M., Eick G., et al. The molecular genetics of gastroenteropancreatic neuroendocrine tumors. Cancer 104 (2005) 2292-2309